
    
      Healthy adolescents and adults received 3 doses of the tetravalent dengue vaccine 5-6 years
      earlier in a previous CYD dengue vaccine trial (CYD28 - NCT00880893) received either a
      booster injection of CYD dengue vaccine or a placebo on Day 0. They were evaluated for safety
      and antibody persistence of the booster injection up to 2 years post-vaccination.
    
  